<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Torgersen J</submitter><funding>National Institutes on Alcohol Abuse and Alcoholism</funding><funding>NCATS NIH HHS</funding><funding>National Cancer Institute</funding><funding>NIAAA NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>747-755</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7357318</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>112(7)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Despite increasing incidence of hepatocellular carcinoma (HCC) among HIV-infected patients, it remains unclear if HIV-related factors contribute to development of HCC. We examined if higher or prolonged HIV viremia and lower CD4+ cell percentage were associated with HCC.&lt;h4>Methods&lt;/h4>We conducted a cohort study of HIV-infected individuals who had HIV RNA, CD4+, and CD8+ cell counts and percentages assessed in the Veterans Aging Cohort Study (1999-2015). HCC was ascertained using Veterans Health Administration cancer registries and electronic records. Cox regression was used to determine hazard ratios (HR, 95% confidence interval [CI]) of HCC associated with higher current HIV RNA, longer duration of detectable HIV viremia (≥500 copies/mL), and current CD4+ cell percent</pubmed_abstract><journal>Journal of the National Cancer Institute</journal><pubmed_title>HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status.</pubmed_title><pmcid>PMC7357318</pmcid><funding_grant_id>U01 AA013566</funding_grant_id><funding_grant_id>UL1 TR001863</funding_grant_id><funding_grant_id>U01AA013566</funding_grant_id><funding_grant_id>R01 CA206465</funding_grant_id><funding_grant_id>R01CA206465</funding_grant_id><pubmed_authors>Rodriguez-Barradas MC</pubmed_authors><pubmed_authors>Brau N</pubmed_authors><pubmed_authors>Carbonari DM</pubmed_authors><pubmed_authors>Goetz MB</pubmed_authors><pubmed_authors>Mehta RL</pubmed_authors><pubmed_authors>Tate JP</pubmed_authors><pubmed_authors>Justice AC</pubmed_authors><pubmed_authors>Lo Re V</pubmed_authors><pubmed_authors>Gibert CL</pubmed_authors><pubmed_authors>Park LS</pubmed_authors><pubmed_authors>Kallan MJ</pubmed_authors><pubmed_authors>D'Addeo K</pubmed_authors><pubmed_authors>Brown ST</pubmed_authors><pubmed_authors>Roy JA</pubmed_authors><pubmed_authors>Taddei TH</pubmed_authors><pubmed_authors>Lim JK</pubmed_authors><pubmed_authors>Torgersen J</pubmed_authors></additional><is_claimable>false</is_claimable><name>HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status.</name><description>&lt;h4>Background&lt;/h4>Despite increasing incidence of hepatocellular carcinoma (HCC) among HIV-infected patients, it remains unclear if HIV-related factors contribute to development of HCC. We examined if higher or prolonged HIV viremia and lower CD4+ cell percentage were associated with HCC.&lt;h4>Methods&lt;/h4>We conducted a cohort study of HIV-infected individuals who had HIV RNA, CD4+, and CD8+ cell counts and percentages assessed in the Veterans Aging Cohort Study (1999-2015). HCC was ascertained using Veterans Health Administration cancer registries and electronic records. Cox regression was used to determine hazard ratios (HR, 95% confidence interval [CI]) of HCC associated with higher current HIV RNA, longer duration of detectable HIV viremia (≥500 copies/mL), and current CD4+ cell percent</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2025-04-04T08:18:31.162Z</modification><creation>2020-11-08T09:45:25Z</creation></dates><accession>S-EPMC7357318</accession><cross_references><pubmed>31687755</pubmed><doi>10.1093/jnci/djz214</doi></cross_references></HashMap>